Skip to content

Based on my review, I'll provide a comprehensive assessment of the GO-CAM model for IL1beta-mediated signaling pathway (Human) with ID gomodel:59cc772c00000000.

Review of GO-CAM Model: IL1beta-mediated signaling pathway (Human)

Summary of the Model

The model gomodel:59cc772c00000000 represents the IL-1β-mediated signaling pathway in humans. It captures the following key components and interactions:

  1. IL-1β cytokine signaling: IL-1β (P01584) functions as a cytokine that initiates the signaling cascade
  2. Receptor recognition: IL-1β binds to and activates the IL-1 receptor type 1 (IL1R1/P14778)
  3. Co-receptor involvement: IL-1RAP (Q9NPH3) acts as a co-receptor
  4. Adaptor recruitment: MYD88 (Q99836) functions as a molecular adaptor
  5. Kinase activation cascade: IRAK4 (Q9NWZ3) → IRAK1 (P51617) → MAP3K7 (O43318)
  6. Processing component: Caspase-1 (P29466) processes pro-IL-1β to mature IL-1β

Strengths of the Model

  1. Proper biological pathway representation: The model correctly represents the canonical IL-1β signaling pathway, with appropriate molecular functions assigned to each component.

  2. Appropriate use of causal relationships: The model uses the correct causal relationships (RO:0002629 "directly positively regulates") to connect components in the pathway.

  3. Correct subcellular localization: Components are assigned appropriate cellular locations (e.g., IL-1β in extracellular region, IL1R1 in plasma membrane, IRAK4/IRAK1 in cytoplasm).

  4. Evidence-based annotations: Most key relationships are supported by experimental evidence with appropriate literature citations.

  5. Consistent with signaling receptor guidelines: The model follows the GO-CAM guidelines for signaling receptor activity, where:

  6. IL-1β has cytokine activity (GO:0005125)
  7. IL-1R1 has interleukin-1 receptor activity (GO:0004908)
  8. IL1RAP has coreceptor activity (GO:0015026)

Areas for Improvement

  1. Missing NIK-IKK module: The signaling cascade typically continues through NF-κB activation via NIK (MAP3K14) and IKK complex, which aren't represented in the current model.

  2. Incomplete activation cascade: The model shows IRAK1 activating MAP3K7, but doesn't show TAK1-binding proteins (TAB1/2) which are essential for MAP3K7 activation.

  3. Unconnected component in pathway: Caspase-1 (CASP1) activity is shown as processing pro-IL1β, but it appears disconnected from the main signaling cascade (this is accurate biologically as inflammasome activation is somewhat separate from IL-1 signaling).

  4. Incompletely characterized activity: MAP3K7 (O43318) activity is represented with the generic "kinase activity" (GO:0016301) rather than a more specific protein kinase activity term.

  5. Missing biochemical output: The model doesn't show the ultimate biochemical outputs of the pathway (e.g., NF-κB activation, gene expression changes).

  6. Annotation evidence gaps: Some relationships lack full evidence annotations:

  7. The causal association between IRAK1 (gomodel:59cc772c00000000/59cc772c00000024) and MAP3K7 (gomodel:59cc772c00000000/59cde02c00000027) lacks evidence

Consistency with GO-CAM Best Practices

The model generally follows GO-CAM best practices. Particularly:

  1. Receptor-ligand representation: Follows the signaling receptor activity guidelines with appropriate relationship between ligand (IL-1β), receptor (IL1R1), and co-receptor (IL1RAP).

  2. Molecular adaptor annotation: Correctly represents molecular adaptors (MYD88, TOLLIP) following the molecular adaptor guidelines with "has input" relationships to specify interacting partners.

  3. Causal relationships: Uses appropriate causal relationship predicates (RO:0002629 "directly positively regulates") throughout the model.

Biological Accuracy

The model accurately represents the core components of the IL-1β signaling pathway:

  1. IL-1β activation: The model correctly shows CASP1 processing IL-1β, which is a key step in IL-1β maturation.

  2. Receptor complex formation: The model appropriately shows IL-1β binding to IL-1R1, with IL1RAP serving as co-receptor.

  3. Adaptor recruitment: The recruitment of MYD88 and TOLLIP adaptors is biologically accurate.

  4. Kinase cascade: The activation sequence IRAK4 → IRAK1 → MAP3K7 is consistent with literature evidence, including the PMID:11960013 reference that emphasizes IRAK4's role upstream of IRAK1.

Recommendations for Improvement

  1. Complete the signaling cascade: Add downstream components showing MAP3K7 activation of the IKK complex and subsequent NF-κB activation.

  2. Add TAB1/2 adaptors: Include TAB1/2 proteins which connect IRAK1 to MAP3K7 activation.

  3. Use more specific molecular function terms: Replace generic "kinase activity" with more specific terms where appropriate, such as "protein serine/threonine kinase activity" for MAP3K7.

  4. Add pathway outcomes: Include the biological outcomes of this pathway, particularly NF-κB activation and target gene expression.

  5. Complete evidence annotations: Provide missing evidence for the IRAK1-MAP3K7 connection.

  6. Consider including negative regulators: The pathway has several negative regulators (e.g., IL1RN, IRAK3) that could be added to more completely represent physiological regulation.

Conclusion

The GO-CAM model gomodel:59cc772c00000000 provides a solid representation of the core IL-1β signaling pathway with appropriate molecular functions, cellular locations, and causal relationships between components. The model adheres to GO-CAM best practices for representing signaling pathways and receptor-ligand interactions. While some enhancements could be made to represent the full signaling cascade and its outcomes, the current model accurately captures the key aspects of IL-1β-mediated signaling.